These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 7055012

  • 1. Agonists and antagonists of 5-hydroxytryptamine on venomotor receptors.
    Aellig WH.
    Adv Neurol; 1982; 33():321-4. PubMed ID: 7055012
    [No Abstract] [Full Text] [Related]

  • 2. Effects on arterial receptors of ergot derivatives used in migraine.
    Müller-Schweinitzer E, Fanchamps A.
    Adv Neurol; 1982; 33():343-56. PubMed ID: 6275676
    [No Abstract] [Full Text] [Related]

  • 3. Potentiation and antagonism of serotonin effects on intracranial and extracranial vessels. Possible implications in migraine.
    Hardebo JE, Edvinsson L, Owman C, Svendgaard NA.
    Neurology; 1978 Jan; 28(1):64-70. PubMed ID: 563539
    [Abstract] [Full Text] [Related]

  • 4. [Serotonin agonists and antagonists in migraine].
    Ollat H.
    Pathol Biol (Paris); 1992 Apr; 40(4):389-96. PubMed ID: 1353874
    [Abstract] [Full Text] [Related]

  • 5. Agonists and antagonists of vascular receptors.
    Saxena PR.
    Adv Neurol; 1982 Apr; 33():309-14. PubMed ID: 7034489
    [No Abstract] [Full Text] [Related]

  • 6. [Serotonin and antiserotonergic agents].
    Bourin M.
    Rev Prat; 1990 Jun 21; 40(18):1711-3. PubMed ID: 2371526
    [No Abstract] [Full Text] [Related]

  • 7. Evidence for stimulation of 5-HT receptors in canine saphenous arteries by ergotamine.
    Müller-Schweinitzer E.
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct 21; 295(1):41-4. PubMed ID: 1004641
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effect of migraine and ergot upon reflex vasodilatation to radiant heating.
    Macmillan AL, Hockaday J.
    Bibl Anat; 1967 Oct 21; 9():343-7. PubMed ID: 6029885
    [No Abstract] [Full Text] [Related]

  • 12. [Classification, pathogenesis and drug therapy of migraine and related forms of headache].
    Fanchamps A.
    Med Welt; 1975 Aug 29; 6(35):1518-23. PubMed ID: 241000
    [No Abstract] [Full Text] [Related]

  • 13. Biochemical pharmacological profile of migraine prophylactics of pizotifen type.
    Dlohozková N, Metys J, Valchár M, Soucek R.
    Act Nerv Super (Praha); 1989 Dec 29; 31(4):300-1. PubMed ID: 2638122
    [No Abstract] [Full Text] [Related]

  • 14. The animal pharmacology of drugs used in the treatment of migraine.
    Fozard JR.
    J Pharm Pharmacol; 1975 May 29; 27(5):297-321. PubMed ID: 239131
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. An introduction to migraine: from ancient treatment to functional pharmacology and antimigraine therapy.
    Villalón CM, Centurión D, Valdivia LF, De Vries P, Saxena PR.
    Proc West Pharmacol Soc; 2002 May 29; 45():199-210. PubMed ID: 12434581
    [Abstract] [Full Text] [Related]

  • 17. [The world of serotonin and its receptors. Physiopathologic, clinical, and therapeutic aspects].
    Marco Igual M.
    Med Clin (Barc); 1993 Jun 19; 101(4):144-53. PubMed ID: 8355545
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.